(Q37143606)

18 August 2017

1 reference

title

Endocannabinoids, adipose tissue and lipid metabolism (English)

1 reference

18 August 2017

0 references

C Pagano

1

1 reference

18 August 2017

M Rossato

series ordinal

2

1 reference

18 August 2017

R Vettor

series ordinal

3

1 reference

18 August 2017

publication date

1 May 2008

1 reference

Journal of Neuroendocrinology

18 August 2017

published in

1 reference

18 August 2017

volume

20 Suppl 1

1 reference

18 August 2017

page(s)

124-129

1 reference

Leptin-regulated endocannabinoids are involved in maintaining food intake

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01690.X

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01690.X

The emerging role of the endocannabinoid system in endocrine regulation and energy balance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01690.X

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01690.X

Cannabinoids go nuclear: evidence for activation of peroxisome proliferator-activated receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01690.X

Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01690.X

Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01690.X

Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01690.X

Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01690.X

Regulation, function, and dysregulation of endocannabinoids in models of adipose and beta-pancreatic cells and in obesity and hyperglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01690.X

The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01690.X

Antiobesity effects of chronic cannabinoid CB1 receptor antagonist treatment in diet-induced obese mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01690.X

Human adipose tissue binds and metabolizes the endocannabinoids anandamide and 2-arachidonoylglycerol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01690.X

Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01690.X

Effects of the cannabinoid CB1 receptor antagonist SR141716 on oxygen consumption and soleus muscle glucose uptake in Lep(ob)/Lep(ob) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01690.X

The biology of peroxisome proliferator-activated receptors: relationship with lipid metabolism and insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01690.X

PPARs, Obesity, and Inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01690.X

Immunolocalization of peroxisome proliferator-activated receptors and retinoid X receptors in the adult rat CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01690.X

Expression of peroxisome proliferator-activated receptors (PPARs) and retinoic acid receptors (RXRs) in rat cortical neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01690.X

The specificity of Sushi peptides for endotoxin and anionic phospholipids: potential application of POPG as an adjuvant for anti-LPS strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01690.X

15-Lipoxygenase metabolism of 2-arachidonylglycerol. Generation of a peroxisome proliferator-activated receptor alpha agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01690.X

Activation and Binding of Peroxisome Proliferator-Activated Receptor γ by Synthetic Cannabinoid Ajulemic Acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01690.X

Novel time-dependent vascular actions of Delta9-tetrahydrocannabinol mediated by peroxisome proliferator-activated receptor gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01690.X

Anandamide induced PPARgamma transcriptional activation and 3T3-L1 preadipocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01690.X

Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01690.X

Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01690.X

Oleoylethanolamide stimulates lipolysis by activating the nuclear receptor peroxisome proliferator-activated receptor alpha (PPAR-alpha).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01690.X

Rapid broad-spectrum analgesia through activation of peroxisome proliferator-activated receptor-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01690.X

PPAR delta: a dagger in the heart of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01690.X

Exercise reduces adipose tissue via cannabinoid receptor type 1 which is regulated by peroxisome proliferator-activated receptor-delta

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01690.X

10.1111/J.1365-2826.2008.01690.X

21 January 2018

Identifiers

DOI

1 reference

18 August 2017

1 reference